SEC Filing Summary: Safety Shot, Inc. (8-K)
Business Context and Reporting Period
Company: Safety Shot, Inc. (Note: Input metadata referenced "BONK, INC." but the filing text identifies the registrant as Safety Shot, Inc.)
Reporting Date: February 4, 2025
Exchange: The Nasdaq Capital Market (Ticker: SHOT, Warrants: SHOTW)
Status: Emerging Growth Company
The Company entered into a Material Definitive Agreement (Securities Purchase Agreement) with one accredited investor to raise capital through a private placement.
Key Financial Metrics and Transaction Details
| Metric | Value |
|---|---|
| Gross Proceeds | $1,165,198.24 |
| Common Shares Issued (PIPE) | 2,753,304 |
| Warrants Issued | 2,753,304 |
| Price per Common Share | $0.3632 |
| Price per Warrant | $0.06 |
| Warrant Exercise Price | $0.45 |
| Warrant Term | 5 Years |
Note: The filing does not provide current revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses solely on the capital raise transaction.
Material Changes and Transaction Structure
- Capital Raise: The Company secured approximately $1.17 million in gross proceeds via a Private Investment in Public Equity (PIPE) transaction.
- Instrument Structure: The deal consists of a 1:1 ratio of Common Stock to Warrants.
- Regulatory Status: Securities were issued without prior registration, relying on exemptions under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.
- Warrant Terms: Warrants are exercisable at $0.45 per share, which is higher than the purchase price of the underlying common stock ($0.3632).
Guidance, Outlook, and Risks
Management Commentary: The filing contains no specific forward-looking guidance, outlook statements, or management commentary regarding future operations beyond the execution of the SPA.
Risks and Contingencies:
- Dilution: The issuance of 2,753,304 new shares and associated warrants will result in immediate dilution to existing shareholders.
- Unregistered Securities: The transaction relies on specific regulatory exemptions; failure to comply could impact the validity of the issuance.
- Warrant Exercise: Future dilution may occur if the stock price rises above the $0.45 exercise price, prompting warrant holders to exercise their options.
Investor Verification Checklist
- Verify the current share count and fully diluted share count to assess the percentage dilution from this transaction.
- Confirm the identity of the "accredited investor" to evaluate potential conflicts of interest or strategic value.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for any restrictive covenants, registration rights, or liquidation preferences.
- Check the Company's latest 10-K or 10-Q for current cash balances to determine the runway provided by the $1.17 million raise.
- Monitor the stock price relative to the $0.45 warrant strike price to gauge the likelihood of future dilution.